title: [Vardenafil significantly alleviates erectile dysfunction in aged men with diabetes].
abstract: OBJECTIVE
  To observe the efficacy and safety of vardenafil in the treatment of erectile dysfunction (ED) in aged men with diabetes mellitus (DM).
  
  
  METHODS
  One hundred outpatients with diagnosed ED (40 diabetic and 60 non-diabetic) received vardenafil at the initial dose of 20 mg and sustained dose of 10 mg once a week for 8 weeks, and their erectile functions were evaluated by IIEF and EQS.
  
  
  RESULTS
  The scores on IIEF and EQS in the diabetic ED group were 18.9 +/- 0.2 and 25.1 +/- 1.4 after the vardenafil treatment, significantly higher than 8.1 +/- 0.5 and 9.1 +/- 1.3 before the treatment (P < 0.01), and the non-diabetic group scored 21.1 +/- 0.2 and 34.2 +/- 1.2 on IIEF and EQS after the treatment, as compared with the statistically lower scores of 10.1 +/- 0.3 and 10.1 +/- 1.7 before it (P < 0.01). The total rate of effectiveness was 65% in the diabetic and 73.30% in the non-diabetic group, with statistical differences (P < 0. 05).
  
  
  CONCLUSIONS
  Vardenafil can significantly improve erectile function and is well tolerated in the aged males with diabetic ED.
authors.affiliation: Department of Urology, Second People's Hospital of Shenzhen, Shenzhen, Guangdong 518035, China. zwzchi@163.com
authors.forename: Zhong-Lin
authors.initials: ZL
authors.lastname: Zhang
authors.forename: Huo-Jin
authors.initials: HJ
authors.lastname: Li
authors.forename: Wan-Hua
authors.initials: WH
authors.lastname: Zhen
authors.forename: Rong
authors.initials: R
authors.lastname: Yuan
mesh_terms: D000368:Aged; D000375:Aging / Q000502:physiology*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use*; D013450:Sulfones / Q000627:therapeutic use; D016896:Treatment Outcome; D014227:Triazines / Q000627:therapeutic use; D000069058:Vardenafil Dihydrochloride
chemical_list: D007093:Imidazoles; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D013450:Sulfones; D014227:Triazines; D000069058:Vardenafil Dihydrochloride